Pharma-Brief Spezial English

The Corona pandemic ignited a global health crisis. It caused care systems to collapse or brought them to the brink of their breaking point.

Resistant bacteria are spreading worldwide. In collaboration with partners in India, Tanzania, South Africa and Germany, we have investigated the causes and consequences of this spread.

Antibiotics have been a blessing for medicine. Their discovery meant that infections which had previously caused great suffering and many deaths could now be treated.

BUKO Pharma-Kampagne and HEPS Uganda have scrutinised the business behaviour of the pharma companies Bayer, Boehringer Ingelheim and Baxter in Uganda.

BUKO Pharma-Kampagne has carefully examined the business behaviour of Bayer Health Care, Boehringer Ingelheim and Baxter in Brazil.

BUKO Pharma-Kampagne and the Institute of Public Health Bangalore/ India have made a survey of the business behavior of Bayer Health Care, Boehringer Ingelheim and Baxter in India.

Malaria is considered to be a tropical disease today. In earlier days, however, it also caused much suffering in Europe.

Whereas HIV/Aids is regarded as a controllable chronic disease in the western world, the situation for large parts of the world´s population is dramatic.

Public funding often plays a key role in research and development (R & D) of new medicines. But innovative drugs are often not affordable for people in poor countries.

The present booklet examines tuberculosis as a social disease around the turn of the 19th to the 20th century and today.

Tuberculosis (TB) is the most common infectious disease in the world. One third of the world population – around two billion people – are carriers of the mycobacterium tuberculosis.